Caricamento...

Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents

Recently, we reported on potent EphA2 targeting compounds and demonstrated that dimeric versions of such agents can exhibit remarkably increased agonistic activity in cellular assays compared to the monomers. Here we further characterize the activity of dimeric compounds at the structural, biochemic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmaceuticals (Basel)
Autori principali: Salem, Ahmed F., Gambini, Luca, Udompholkul, Parima, Baggio, Carlo, Pellecchia, Maurizio
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7281375/
https://ncbi.nlm.nih.gov/pubmed/32397624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13050090
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !